TNDM

Tandem Diabetes Care, Inc. NASDAQ

Healthcare ·Medical - Devices ·US · tandemdiabetes.com

$19.42

Mkt Cap $1.3B

52w Low $9.98 48.0% of range 52w High $29.65

50d MA $21.72 200d MA $18.04

P/E (TTM) -6.4x

EV/EBITDA -10.5x

P/B 8.4x

Debt/Equity 2.9x

ROE -0.4%

P/FCF -49.8x

RSI (14) —

ATR (14) —

Beta 1.74

50d MA $21.72

200d MA $18.04

Avg Volume 2.1M

About

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:sli…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 19, 2026	AMC	-0.05	-0.01	+80.0%	18.52	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%	—
Nov 6, 2025	AMC	-0.31	-0.31	+0.0%	13.33	+20.0%	+22.0%	+22.8%	+31.4%	+35.5%	+31.5%	—
Aug 6, 2025	AMC	-0.40	-0.48	-20.0%	14.39	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%	—
Apr 30, 2025	AMC	-0.60	-0.67	-11.7%	16.85	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%	—
Feb 26, 2025	AMC	-0.25	-0.44	-76.0%	33.59	-28.0%	-35.2%	-34.1%	-38.1%	-42.0%	-43.1%	—
Nov 6, 2024	AMC	-0.43	-0.36	+16.3%	34.24	-4.8%	-2.7%	-10.6%	-8.4%	-9.2%	-13.3%	—
Aug 1, 2024	AMC	-0.54	-0.47	+13.0%	35.21	+17.2%	+18.3%	+15.8%	+23.2%	+5.2%	+4.7%	—
May 2, 2024	AMC	-0.80	-0.63	+21.2%	36.56	+17.4%	+22.3%	+19.0%	+20.4%	+15.3%	+20.5%	—
Feb 21, 2024	AMC	-0.23	-0.27	-17.4%	22.55	+8.6%	+10.9%	+29.2%	+28.0%	+21.2%	+17.9%	—
Nov 1, 2023	AMC	-0.35	-0.38	-8.6%	17.75	-11.3%	-14.4%	-11.3%	-13.7%	-8.4%	-12.6%	—
Aug 3, 2023	AMC	-0.54	-0.30	+44.4%	31.99	-6.6%	+4.4%	-5.8%	-12.1%	-10.5%	-8.4%	—
May 3, 2023	AMC	-0.56	-0.63	-12.5%	39.95	-11.9%	-6.1%	-12.2%	-16.3%	-18.1%	-16.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	TD Cowen	Maintains	Buy → Buy	—	$20.61	$20.88	+1.3%	+3.1%	-2.8%	+0.8%	+0.3%	-1.2%
Apr 9	Goldman Sachs	Maintains	Neutral → Neutral	—	$19.35	$19.34	-0.1%	+1.7%	-0.9%	+3.9%	+9.1%	+6.8%
Mar 19	Truist	Upgrade	Hold → Buy	—	$23.85	$25.04	+5.0%	+3.3%	+4.1%	+5.2%	+2.8%	+1.7%
Mar 17	Piper Sandler	Upgrade	Neutral → Overweight	—	$21.91	$23.16	+5.7%	+9.1%	+8.9%	+12.4%	+13.3%	+14.5%
Mar 2	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$25.30	$24.88	-1.7%	-0.3%	-6.2%	-7.5%	-10.6%	-16.4%
Feb 23	Lake Street	Upgrade	Hold → Buy	—	$24.57	$25.59	+4.2%	+15.0%	+9.5%	+5.9%	+5.0%	+3.0%
Feb 23	Truist	Maintains	Hold → Hold	—	$24.57	$25.59	+4.2%	+15.0%	+9.5%	+5.9%	+5.0%	+3.0%
Feb 20	BofA Securities	Upgrade	Underperform → Neutral	—	$18.52	$22.75	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%
Feb 20	Piper Sandler	Maintains	Neutral → Neutral	—	$18.52	$22.75	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%
Feb 20	UBS	Maintains	Neutral → Neutral	—	$18.52	$22.75	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%
Feb 20	Stifel	Maintains	Hold → Hold	—	$18.52	$22.75	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%
Feb 20	Mizuho	Maintains	Neutral → Neutral	—	$18.52	$22.75	+22.8%	+32.7%	+52.6%	+45.2%	+40.4%	+39.3%
Feb 4	Stifel	Maintains	Hold → Hold	—	$19.44	$19.44	+0.0%	-2.3%	-2.6%	-1.4%	-2.8%	+0.5%
Jan 9	Bernstein	Maintains	Market Perform → Market Perform	—	$22.50	$23.03	+2.4%	-3.6%	-5.1%	-7.1%	-7.2%	-6.4%
Dec 18	Truist	Maintains	Hold → Hold	—	$22.42	$22.44	+0.1%	-2.8%	-1.6%	+3.7%	+0.9%	+0.3%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$22.60	$22.67	+0.3%	-0.8%	-3.5%	-2.3%	+2.9%	+0.1%
Dec 17	Mizuho	Maintains	Neutral → Neutral	—	$22.60	$22.67	+0.3%	-0.8%	-3.5%	-2.3%	+2.9%	+0.1%
Dec 16	Baird	Upgrade	Neutral → Outperform	—	$22.11	$24.46	+10.6%	+2.2%	+1.4%	-1.4%	-0.2%	+5.2%
Dec 11	Citigroup	Maintains	Neutral → Neutral	—	$21.45	$20.78	-3.1%	-2.2%	-0.3%	+3.1%	+5.4%	+4.5%
Dec 2	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$20.51	$20.73	+1.1%	-4.3%	-2.8%	+1.0%	+2.0%	+1.1%
Nov 10	Truist	Maintains	Hold → Hold	—	$16.26	$16.51	+1.5%	+0.7%	+7.7%	+11.1%	+7.8%	+14.5%
Nov 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$16.26	$16.51	+1.5%	+0.7%	+7.7%	+11.1%	+7.8%	+14.5%
Nov 10	Barclays	Maintains	Overweight → Overweight	—	$16.26	$16.51	+1.5%	+0.7%	+7.7%	+11.1%	+7.8%	+14.5%
Nov 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$13.33	$16.00	+20.0%	+22.0%	+22.8%	+31.4%	+35.5%	+31.5%
Oct 15	Truist	Maintains	Hold → Hold	—	$14.38	$14.52	+1.0%	+2.6%	+6.3%	+2.9%	+8.1%	+7.0%
Oct 7	Citigroup	Maintains	Neutral → Neutral	—	$15.01	$15.14	+0.9%	-3.3%	+2.2%	-1.3%	-6.7%	-7.6%
Sep 29	Canaccord Genuity	Maintains	Buy → Buy	—	$12.00	$12.08	+0.7%	-1.8%	+1.2%	+3.4%	+9.2%	+22.6%
Sep 8	Oppenheimer	Maintains	Outperform → Outperform	—	$12.58	$12.59	+0.1%	-0.6%	-0.2%	-1.7%	+1.7%	-2.5%
Aug 21	Citigroup	Maintains	Neutral → Neutral	—	$10.68	$10.56	-1.1%	+3.5%	+11.7%	+13.4%	+14.6%	+14.7%
Aug 12	Citigroup	Upgrade	Sell → Neutral	—	$10.12	$11.07	+9.4%	+9.8%	+10.0%	+5.3%	+6.9%	+7.1%
Aug 11	Lake Street	Downgrade	Buy → Hold	—	$11.23	$11.11	-1.1%	-9.9%	-1.1%	-0.9%	-5.1%	-3.7%
Aug 8	Barclays	Maintains	Overweight → Overweight	—	$11.52	$11.65	+1.1%	-2.5%	-12.2%	-3.6%	-3.4%	-7.5%
Aug 7	RBC Capital	Maintains	Outperform → Outperform	—	$14.39	$10.50	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%
Aug 7	Piper Sandler	Downgrade	Overweight → Neutral	—	$14.39	$10.50	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%
Aug 7	Canaccord Genuity	Maintains	Buy → Buy	—	$14.39	$10.50	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%
Aug 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$14.39	$10.50	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%
Aug 7	UBS	Maintains	Neutral → Neutral	—	$14.39	$10.50	-27.0%	-19.9%	-22.0%	-29.7%	-22.8%	-22.7%
Jul 9	Citigroup	Downgrade	Neutral → Sell	—	$16.62	$15.34	-7.7%	-4.6%	-2.7%	-6.2%	-5.2%	-8.5%
May 22	Citigroup	Maintains	Neutral → Neutral	—	$21.65	$21.58	-0.3%	-4.7%	-4.3%	-0.8%	-2.3%	-1.7%
May 1	Stifel	Maintains	Buy → Buy	—	$16.85	$18.66	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%
May 1	Canaccord Genuity	Maintains	Buy → Buy	—	$16.85	$18.66	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%
May 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$16.85	$18.66	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%
May 1	Baird	Maintains	Neutral → Neutral	—	$16.85	$18.66	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%
May 1	Piper Sandler	Maintains	Overweight → Overweight	—	$16.85	$18.66	+10.7%	+18.6%	+27.5%	+26.4%	+26.5%	+32.1%
Mar 5	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$19.49	$19.18	-1.6%	-1.9%	-4.0%	-7.9%	-6.8%	-8.2%
Mar 4	Citigroup	Downgrade	Buy → Neutral	—	$20.78	$20.00	-3.8%	-6.2%	-8.0%	-9.9%	-13.6%	-12.6%
Mar 3	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$22.14	$21.83	-1.4%	-6.1%	-12.0%	-13.7%	-15.4%	-18.9%
Mar 3	Goldman Sachs	Maintains	Neutral → Neutral	—	$22.14	$21.83	-1.4%	-6.1%	-12.0%	-13.7%	-15.4%	-18.9%
Feb 28	Barclays	Maintains	Overweight → Overweight	—	$21.75	$21.68	-0.3%	+1.8%	-4.5%	-10.4%	-12.1%	-13.9%
Feb 27	RBC Capital	Maintains	Outperform → Outperform	—	$33.59	$24.18	-28.0%	-35.2%	-34.1%	-38.1%	-42.0%	-43.1%

Recent Filings

8-K · 1.01 !! High

Tandem Diabetes Care, Inc. -- 8-K 1.01: Material Agreement

Tandem Diabetes Care issued convertible notes on February 27, 2026, providing capital for operations and potential acquisitions while giving investors conversion rights into company stock.

Feb 27

8-K

Tandem Diabetes Care, Inc. -- 8-K Filing

Tandem Diabetes Care reported Q4 and full-year 2025 financial results, providing 2026 guidance as a global insulin delivery company navigates ongoing market dynamics.

Feb 19

Data updated apr 27, 2026 5:10am · Source: massive.com